ZimVie Inc. ( ZIMV ) NASDAQ Global Select

Cena: 8.96 ( 1.13% )

Aktualizacja 06-25 22:00
NASDAQ Global Select
Branża: Medical - Devices

Notowania:


Informacje o spółce:
Sektor: Zdrowie
Branża: Medical - Devices
Zatrudnienie: 2 600
Giełda: NASDAQ Global Select
Ilość akcji w obrocie: 97%
Ilość akcji: 26 534 000
Debiut giełdowy: 2022-02-16
WWW: https://www.zimvie.com
CEO: Mr. Vafa Jamali
Adres: 10225 Westmoor Drive
Siedziba: 80021 Westminster
ISIN: US98888T1079
Opis firmy:

Zimvie Inc., firma zajmująca się technologią medyczną, rozwija, produkuje i dostarcza portfolio produktów i rozwiązań zaprojektowanych w celu leczenia szeregu patologii kręgosłupa oraz wspierania procedur wymiany zębów dentystycznych na całym świecie. Oferuje systemy implantów dentystycznych, produkty protetyczne i zaczepowe, oprzyrządowanie chirurgiczne i zestawy; Przeszczepy kostne, błony barierowe, przeszczepy alloprzeszczepowe i produkty do pielęgnacji ran kolagenowych; Skanery wewnątrzustne; oraz usługi wirtualnego planowania leczenia, roztwory chirurgiczne z przewodnikiem, systemy przepływu pracy CAD/CAM oraz specyficzne dla pacjenta komponenty odbudowy i skanery wewnątrzustne, a także implanty fuzji kręgosłupa i oprzyrządowanie dla różnych zabiegów kręgosłupa, biologicznych i gojeniach. Firma zapewnia również MIS Solutions, takie jak Vital MIS i Timberline; oraz rozwiązania dotyczące konserwacji ruchu, w tym MOBI-C i uwięzi. Zimvie Inc. został włączony w 2021 r. I ma siedzibę w Westminster w Kolorado.

Wskaźniki finansowe
Kapitalizacja (USD) 250 177 079
Aktywa: 782 948 000
Cena: 8.96
Wskaźnik Altman Z-Score: 0.5
Słaby (wysokie ryzyko bankructwa)
Dywidenda: 0
P/E: -10.0
Ilość akcji w obrocie: 97%
Średni wolumen: 146 448
Ilość akcji 27 921 549
Wskaźniki finansowe
Przychody TTM 451 294 000
Zobowiązania: 376 310 000
Przedział 52 tyg.: 8.15 - 22.4
Piotroski F-Score: 3
Słaby (niska jakość finansowa)
EPS: -0.9
P/E branży: 26.8
Beta: 1.996
Raport okresowy: 2025-07-31
WWW: https://www.zimvie.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Mr. Richard J. Heppenstall Executive Vice President, Chief Financial Officer & Treasurer 665 371 1971
Ms. Heather Kidwell Senior Vice President, Chief Legal, HR & Compliance Officer and Corporate Secretary 568 536 1969
Mr. Indraneel Kanaglekar Senior Vice President & Chief Commercial Officer 459 736 1978
Mr. Vafa Jamali President, Chief Executive Officer & Director 1 226 942 1970
Sandra Schneider Chief Accounting Officer 0 0
Mr. Steve Rondeau Senior Vice President & Chief Information Officer 0 0
Ms. Ann Vu SVice President & Chief Quality and Regulatory Affairs Officer 0 0
Wiadomości dla ZimVie Inc.
Tytuł Treść Źródło Aktualizacja Link
ZimVie to Participate in the Stifel 2025 Jaws & Paws Conference PALM BEACH GARDENS, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced management will participate in the upcoming Stifel 2025 Jaws & Paws Conference. Management will be presenting on Wednesday, May 28, 2025 at 3:00 p.m. Eastern Time / 12:00 p.m. Pacific Time. globenewswire.com 2025-05-14 20:05:00 Czytaj oryginał (ang.)
ZimVie Inc. (ZIMV) Q1 2025 Earnings Call Transcript ZimVie Inc. (NASDAQ:ZIMV ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Webb Campbell - Investor Relations Vafa Jamali - President & Chief Executive Officer Richard Heppenstall - Chief Financial Officer Conference Call Participants Dylan Finley - UBS Anderson Schock - B. Riley Securities Matthew Miksic - Barclays Bank Operator Good afternoon, and welcome to ZimVie's First Quarter 2025 Earnings Conference Call. seekingalpha.com 2025-05-11 11:18:59 Czytaj oryginał (ang.)
ZimVie Reports First Quarter 2025 Financial Results Net Sales from Continuing Operations of $112.0 million Net Loss from Continuing Operations of $(2.6) million; Net Loss margin of (2.3)% Adjusted EBITDA [ 1] from Continuing Operations of $17.6 million; Adjusted EBITDA [1] margin of 15.7% GAAP diluted EPS from Continuing Operations of $(0.09) and adjusted diluted EPS [1] from Continuing Operations of $0.27 PALM BEACH GARDENS, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today reported financial results for the quarter ended March 31, 2025. globenewswire.com 2025-05-08 20:05:00 Czytaj oryginał (ang.)
ZimVie to Report First Quarter 2025 Financial Results on May 8, 2025 PALM BEACH GARDENS, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the first quarter 2025 after market close on Thursday, May 8, 2025. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. globenewswire.com 2025-04-24 20:05:00 Czytaj oryginał (ang.)
ZimVie Pioneers the Future of Molar Restoration with New Immediate Molar Dental Implant System PALM BEACH GARDENS, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced the launch of its Immediate Molar Implant System in the United States. globenewswire.com 2025-04-21 12:00:00 Czytaj oryginał (ang.)
ZimVie to Participate in the 24th Annual Needham Virtual Healthcare Conference PALM BEACH GARDENS, Fla., March 25, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced management will participate in the upcoming 24th Annual Needham Virtual Healthcare Conference. Management will be presenting on Tuesday, April 8, 2025 at 3:00 p.m. Eastern Time / 12:00 p.m. Pacific Time. globenewswire.com 2025-03-25 18:05:00 Czytaj oryginał (ang.)
ZimVie Announces Upcoming Changes to Company's Board of Directors PALM BEACH GARDENS, Fla., March 13, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced upcoming changes to the Company's Board of Directors, including: globenewswire.com 2025-03-13 18:15:00 Czytaj oryginał (ang.)
Dental Players Dentsply Sirona, ZimVie Show Weak Growth Outlook: Analyst Dentsply Sirona  XRAY and ZimVie Inc. ZIMV show below-market growth and have no meaningful upside, according Needham analysts. benzinga.com 2025-03-13 16:35:53 Czytaj oryginał (ang.)
ZimVie Inc. (ZIMV) Q4 2024 Earnings Call Transcript ZimVie Inc. (NASDAQ:ZIMV ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Marissa Bych - Investor Relations Vafa Jamali - President & Chief Executive Officer Richard Heppenstall - Chief Financial Officer Conference Call Participants David Saxon - Needham & Company Kevin Caliendo - UBS William McMahon - Barclays Operator Good afternoon and welcome to ZimVie's Fourth Quarter 2024 Earnings Conference Call. Currently, all participants are in a listen-only mode. seekingalpha.com 2025-02-26 21:52:49 Czytaj oryginał (ang.)
ZimVie Reports Fourth Quarter and Full Year 2024 Financial Results PALM BEACH GARDENS, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today reported financial results for the quarter and year ended December 31, 2024. Management will host a corresponding conference call today, February 26, 2025, at 4:30 p.m. Eastern Time. globenewswire.com 2025-02-26 18:05:00 Czytaj oryginał (ang.)
ZimVie to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025 PALM BEACH GARDENS, Fla., Feb. 12, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the fourth quarter and full-year 2024 after market close on Wednesday, February 26, 2025. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. globenewswire.com 2025-02-12 18:05:00 Czytaj oryginał (ang.)
ZimVie Announces Publication of a Study Supporting the Benefits of Its Implant Surface Technologies Data confirms ZimVie implants meet critical roughness criteria advantageous for long-term peri-implant health Data confirms ZimVie implants meet critical roughness criteria advantageous for long-term peri-implant health globenewswire.com 2025-01-30 10:00:00 Czytaj oryginał (ang.)
ZimVie Inc. (ZIMV) Q3 2024 Earnings Call Transcript ZimVie Inc. (NASDAQ:ZIMV ) Q3 2024 Results Conference Call October 30, 2024 4:30 PM ET Company Participants Marissa Bych - IR, Gilmartin Group LLC Vafa Jamali - President and CEO Richard Heppenstall - CFO Conference Call Participants David Saxon - Needham & Company Matt Miksic - Barclays Marissa Bych Thank you all for joining today's call. Earlier today, ZimVie released financial results for the quarter ended September 30, 2024. seekingalpha.com 2024-10-30 21:58:02 Czytaj oryginał (ang.)
ZimVie to Report Third Quarter Financial Results on October 30, 2024 PALM BEACH GARDENS, Fla., Oct. 16, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the third quarter 2024 after market close on Wednesday, October 30, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. globenewswire.com 2024-10-16 20:05:00 Czytaj oryginał (ang.)
Mexico Spinal Implants Market Size, Share & Trends Analysis 2024-2030, with Focus on Market Leaders ZimVie/Highridge Medical, Medtronic and DePuy Synthes Dublin, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The "Mexico Spinal Implants Market Size, Share & Trends Analysis | 2024-2030 | MedSuite | Includes: Cervical Fixation Market, Thoracolumbar Fixation Market, and 4 more" report has been added to ResearchAndMarkets.com's offering. In 2023, Mexico's spinal implant and VCF market reached a valuation exceeding $135 million. Projected to grow at a CAGR of 6.1%, the market is expected to surpass $205 million by 2030. This comprehensive report on the Mexican spinal implant and VCF market covers various segments, including traditional cervical and thoracolumbar fixation devices, interbody devices, motion preservation devices, VCF treatment, electrical stimulation devices, and spinal surgery instrumentation. Key Market Data Insights: globenewswire.com 2024-10-02 16:15:00 Czytaj oryginał (ang.)
ZimVie Inc. (ZIMV) Q2 2024 Earnings Call Transcript ZimVie Inc. (NASDAQ:ZIMV ) Q2 2024 Earnings Conference Call August 1, 2024 4:30 AM ET Company Participants Marissa Bych - IR, Gilmartin Group LLC Vafa Jamali - President and CEO Richard Heppenstall - CFO Conference Call Participants David Saxon - Needham & Company Matt Miksic - Barclays Operator Good afternoon, and welcome to ZimVie's Second Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes. seekingalpha.com 2024-08-04 14:53:09 Czytaj oryginał (ang.)
ZimVie Announces FDA Clearance and U.S. Launch of GenTek® Restorative Components Addition of Premium Restorative Components Enhances ZimVie's End-to-End Implant Offerings Addition of Premium Restorative Components Enhances ZimVie's End-to-End Implant Offerings globenewswire.com 2024-07-23 12:00:00 Czytaj oryginał (ang.)
ZimVie to Report Second Quarter Financial Results on August 1, 2024 PALM BEACH GARDENS, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the second quarter 2024 after market close on Thursday, August 1, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. globenewswire.com 2024-07-18 20:05:00 Czytaj oryginał (ang.)
ZimVie to Participate in Upcoming Investor Conferences PALM BEACH GARDENS, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced that the company will be participating in two upcoming investor conferences. globenewswire.com 2024-05-16 20:05:00 Czytaj oryginał (ang.)
ZimVie Inc. (ZIMV) Q1 2024 Earnings Call Transcript ZimVie Inc. (NASDAQ:ZIMV ) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ET Company Participants Marissa Bych - IR, Gilmartin Group LLC Vafa Jamali - President and CEO Richard Heppenstall - CFO Conference Call Participants Matt Miksic - Barclays Operator Good afternoon and welcome to ZimVie's First Quarter 2024 Earnings Conference Call. Currently, all participants are in a listen-only mode. seekingalpha.com 2024-05-11 10:07:06 Czytaj oryginał (ang.)
ZimVie to Report First Quarter Financial Results on May 8, 2024 PALM BEACH GARDENS, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the first quarter 2024 after market close on Wednesday, May 8, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. globenewswire.com 2024-04-24 20:05:00 Czytaj oryginał (ang.)
ZimVie Announces Closing of Sale of Spine Business Completion of Sale to an Affiliate of H.I.G. Capital for $375 Million Establishes Pure-Play Dental Business Completion of Sale to an Affiliate of H.I.G. Capital for $375 Million Establishes Pure-Play Dental Business globenewswire.com 2024-04-01 12:00:00 Czytaj oryginał (ang.)
ZimVie to Participate in the 23rd Annual Needham Virtual Healthcare Conference WESTMINSTER, Colo., March 27, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced management will participate in the upcoming 23rd Annual Needham Virtual Healthcare Conference. Management will be presenting on Wednesday, April 10th, 2024 at 3:00 p.m. Eastern Time / 12:00 p.m. Pacific Time. globenewswire.com 2024-03-27 10:00:00 Czytaj oryginał (ang.)
ZimVie Inc. (ZIMV) Q4 2023 Earnings Call Transcript ZimVie Inc. (ZIMV) Q4 2023 Earnings Call Transcript seekingalpha.com 2024-02-28 23:52:03 Czytaj oryginał (ang.)
ZimVie to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024 WESTMINSTER, Colo., Feb. 21, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the fourth quarter and full-year 2023 after market close on Wednesday, February 28, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. globenewswire.com 2024-02-21 19:00:00 Czytaj oryginał (ang.)
ZimVie Announces Launch of Next-Generation TSX® Implant in Japan Newest implant innovation is designed for immediacy and peri-implant health Newest implant innovation is designed for immediacy and peri-implant health globenewswire.com 2024-02-07 18:05:00 Czytaj oryginał (ang.)
ZimVie: Focusing On Higher Growth Dental Business (Rating Upgrade) ZimVie's stock has doubled since reporting Q3 earnings, causing investors to wonder about the company's future. The company's Q3 revenues declined less than expected and the company raised full-year guidance. More importantly, ZimVie's decision to sell its spine business for $375 million jettisons an underperforming segment while solving a debt overhang. seekingalpha.com 2023-12-26 21:21:02 Czytaj oryginał (ang.)
ZimVie Inc. (ZIMV) Q3 2023 Earnings Call Transcript ZimVie Inc. (NASDAQ:ZIMV ) Q3 2023 Earnings Conference Call November 1, 2023 4:30 PM ET Company Participants Marissa Bych - Investor Relations, Gilmartin Group LLC Vafa Jamali - President and Chief Executive Officer Richard Heppenstall - Chief Financial Officer Conference Call Participants Lilly Wyttenbach - JPMorgan Matt Miksic - Barclays Operator Good day, and thank you for standing by. Welcome to the ZimVie Third Quarter 2023 Financial Results Conference Call. seekingalpha.com 2023-11-01 23:57:13 Czytaj oryginał (ang.)
ZimVie Announces First U.S. Surgery with the 4.5mm Mobi-C® Cervical Disc WESTMINSTER, Colo., Oct. 31, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that the first patient in the United States has received the newly approved 4.5mm Mobi-C® Cervical Disc. Introduced in France in 2004, Mobi-C became the first cervical disc approved for one and two levels by the FDA in 2013. The smaller 4.5mm height Mobi-C implants, available in seven footprints to match patient anatomy, were approved by the FDA in August of this year. globenewswire.com 2023-10-31 10:00:00 Czytaj oryginał (ang.)
Brace for Impact: 7 Stocks to Sell Amid Rising Troubles While it's an uncomfortable topic, every investor must face the prospect of stocks to sell. Like it or not, market success doesn't just come down to picking winners. investorplace.com 2023-10-18 23:32:50 Czytaj oryginał (ang.)
ZimVie Announces the Launch of Azure™ Multi-Platform Product Solutions New offerings expand ZimVie's dental solutions for lab customers, enhancing selection and broadening the reach of the ZimVie portfolio New offerings expand ZimVie's dental solutions for lab customers, enhancing selection and broadening the reach of the ZimVie portfolio globenewswire.com 2023-10-17 12:30:00 Czytaj oryginał (ang.)
ZimVie (ZIMV) Progresses in Dental Space With Biotivity Launch ZimVie's (ZIMV) Biotivity A/C Plus Membrane is a barrier membrane that contains an array of growth factors. zacks.com 2023-10-12 17:32:41 Czytaj oryginał (ang.)